title: Choroidal thickness is affected by many factors which may change the effect of ranibizumab: author's response.
authors.affiliation: Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa, Japan, 236-0004, nishide@abox3.so-net.ne.jp.
authors.forename: Tadayuki
authors.initials: T
authors.lastname: Nishide
authors.forename: Natsuki
authors.initials: N
authors.lastname: Hayakawa
authors.forename: Etsuko
authors.initials: E
authors.lastname: Shibuya
authors.forename: Yoko
authors.initials: Y
authors.lastname: Yagi
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Mizuki
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002829:Choroid / Q000187:drug effects*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011127:Polyps / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized